|
|
||||||||||||||||||||||||||||||||||||||||||||||
© 2006 The American Thoracic Society Pulmonary VasculitisPulmonary Division, Department of Medicine, National Jewish Medical and Research Center; and Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado Correspondence and requests for reprints should be addressed to Kevin K. Brown, M.D., National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206. E-mail: brownk{at}njc.org ABSTRACT Pulmonary vasculitis describes a number of distinct disorders that are pathologically characterized by the destruction of blood vessels. The clinical manifestations of each disorder are defined by the size, type, and location of the affected vasculature. The clinical approach to these disorders rests upon an astute clinician considering the diagnosis and identifying the specific patterns of clinical, radiologic, laboratory, and pathologic abnormalities. Lung involvement is most commonly seen with the primary, idiopathic, small-vessel, or antineutrophil cytoplasmic antibodyassociated vasculitides; Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome. However, primary, idiopathic medium and large-vessel vasculitis, primary immune complexmediated vasculitis, and secondary vasculitis are all capable of presenting with lung involvement. In this article, we focus on the more common, antineutrophil cytoplasmic antibodyassociated disorder, vasculitides.
Key Words: Churg-Strauss syndrome microscopic polyangiitis vasculitis Wegener's granulomatosis This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||